Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,494 | -23,216 | -30,036 | -28,672 | -25,447 |
| Depreciation Amortization | 1,634 | 2,390 | 1,711 | 1,616 | 2,120 |
| Accounts receivable | -902 | -986 | -1,420 | 217 | 598 |
| Other Working Capital | -95 | -10,888 | -7,443 | -3,402 | 3,005 |
| Other Operating Activity | 3,283 | 8,893 | 3,799 | 246 | 3,241 |
| Operating Cash Flow | $-23,574 | $-23,807 | $-33,389 | $-29,995 | $-16,483 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 0 | 3,975 | 3,879 |
| PPE Investments | -610 | -221 | -393 | 2,612 | -3,138 |
| Purchase Of Investment | -330 | 0 | N/A | -300 | -150 |
| Other Investing Activity | -350 | 0 | 0 | -305 | 0 |
| Investing Cash Flow | $-1,290 | $-221 | $-393 | $5,982 | $591 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 0 | 7,500 | N/A | 600 |
| Debt Repayment | -5,454 | -2,053 | -958 | -1,200 | -952 |
| Common Stock Issued | 52,614 | 27,660 | 29,749 | 23,375 | 17,700 |
| Common Stock Repurchased | N/A | N/A | N/A | 6,000 | N/A |
| Other Financing Activity | -2,482 | -1,336 | -1,363 | -1,599 | -561 |
| Financing Cash Flow | $64,678 | $24,271 | $34,928 | $26,576 | $16,787 |
| Beginning Cash Position | 12,854 | 12,611 | 11,465 | 8,902 | 8,007 |
| End Cash Position | 52,668 | 12,854 | 12,611 | 11,465 | 8,902 |
| Net Cash Flow | $39,814 | $243 | $1,146 | $2,563 | $895 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,574 | -23,807 | -33,389 | -29,995 | -16,483 |
| Capital Expenditure | -610 | -221 | -393 | -563 | -3,138 |
| Free Cash Flow | -24,184 | -24,028 | -33,782 | -30,558 | -19,621 |